Dr. Ankeet Bhatt
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Connecticut School of Medicine (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 11
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: University of Connecticut School of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
MA license 279275 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Kaiser Foundation Hospital - San Francisco San Francisco, CA
Medical groups
- Permanente Medical Group Inc (10,996 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 11
- Services billed
- 14
- Patients’ average age
- 68
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Durham, NC | 13 |
| Diltiazem Hcl Other prescribers in Durham, NC | 12 |
| Ezetimibe Other prescribers in Durham, NC | 12 |
| Metoprolol Succinate Other prescribers in Durham, NC | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 84 payments worth $137,609 in total to this clinician.
| Eko Health, Inc. | $47,923 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $24,671 |
| Bayer HealthCare Pharmaceuticals Inc. | $21,197 |
| Amgen Inc. | $19,328 |
| Esperion Therapeutics, Inc. | $13,200 |
| Merck Sharp & Dohme LLC | $9,335 |
| Novo Nordisk Inc | $1,654 |
| AstraZeneca UK Limited | $207 |
| Consulting Fee | $105,269 |
|---|---|
| Travel and Lodging | $29,202 |
| Food and Beverage | $2,689 |
| Long term medical supply or device loan | $449 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Eko Health, Inc. Sep 3, 2025 | Consulting Fee dividend, profit or | $35,890 |
| Eko Health, Inc. Sep 23, 2025 | Consulting Fee dividend, profit or | $11,584 |
| AstraZeneca Pharmaceuticals LP Mar 5, 2025 | Travel and Lodging travel to Madrid, Spain · in-kind Company’s descriptionResearch Related Service | $11,086 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Consulting Fee Kerendia · Cardio-Renal | $9,490 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 28, 2025 | Consulting Fee Kerendia · Cardio-Renal | $8,950 |
| Amgen Inc. Aug 26, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to Madrid, Spain · in-kind | $8,871 |
| AstraZeneca Pharmaceuticals LP Jul 1, 2025 | Consulting Fee LOKELMA · Cardiovascular and Metabolism | $7,787 |
| Merck Sharp & Dohme LLC May 5, 2025 | Consulting Fee | $7,763 |
| Amgen Inc. Apr 29, 2025 | Consulting Fee Repatha · Cardiovascular | $6,032 |
| Esperion Therapeutics, Inc. Oct 3, 2025 | Consulting Fee NEXLIZET; NEXLETOL · ANTILIPEMIC AGENTS | $5,280 |
All 43 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Nov 19, 2025 | Consulting Fee Cardiovascular | $1,570 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 29, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $86.23 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 28, 2025 | Consulting Fee Kerendia · Cardio-Renal | $8,950 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 28, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $293 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 28, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $197 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 28, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $197 |
| Eko Health, Inc. Oct 16, 2025 | Long term medical supply or device loan in-kind | $449 |
| Esperion Therapeutics, Inc. Oct 3, 2025 | Consulting Fee NEXLIZET; NEXLETOL · ANTILIPEMIC AGENTS | $5,280 |
| Eko Health, Inc. Sep 23, 2025 | Consulting Fee dividend, profit or | $11,584 |
| AstraZeneca Pharmaceuticals LP Sep 5, 2025 | Consulting Fee | $2,250 |
| Eko Health, Inc. Sep 3, 2025 | Consulting Fee dividend, profit or | $35,890 |
| Amgen Inc. Aug 27, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to Madrid, Spain · in-kind | $2,108 |
| Amgen Inc. Aug 27, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to Madrid, Spain · in-kind | $393 |
| Amgen Inc. Aug 26, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to Madrid, Spain · in-kind | $8,871 |
| Esperion Therapeutics, Inc. Jul 14, 2025 | Consulting Fee NEXLIZET; NEXLETOL · ANTILIPEMIC AGENTS | $1,320 |
| AstraZeneca Pharmaceuticals LP Jul 7, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Boston, MA Company’s descriptionConsulting Expenses | $138 |
| AstraZeneca Pharmaceuticals LP Jul 1, 2025 | Consulting Fee LOKELMA · Cardiovascular and Metabolism | $7,787 |
| Esperion Therapeutics, Inc. Jun 23, 2025 | Consulting Fee NEXLIZET; NEXLETOL · ANTILIPEMIC AGENTS | $3,300 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Consulting Fee Kerendia · Cardio-Renal | $9,490 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $263 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $180 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $43.83 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 6, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $330 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 6, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $279 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 6, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Seattle, WA · in-kind | $197 |
| AstraZeneca Pharmaceuticals LP Jun 4, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Boston, MA · in-kind Company’s descriptionConsulting Expenses | $428 |
| AstraZeneca Pharmaceuticals LP Jun 4, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Boston, MA · in-kind Company’s descriptionConsulting Expenses | $428 |
| AstraZeneca Pharmaceuticals LP Jun 3, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Boston, MA · in-kind Company’s descriptionConsulting Expenses | $718 |
| Merck Sharp & Dohme LLC May 5, 2025 | Consulting Fee | $7,763 |
| Merck Sharp & Dohme LLC May 5, 2025 | Travel and Lodging travel to Dallas, TX | $150 |
| Amgen Inc. Apr 29, 2025 | Consulting Fee Repatha · Cardiovascular | $6,032 |
| Amgen Inc. Apr 29, 2025 | Travel and Lodging Repatha · Cardiovascular · travel to CHIGAO, IL | $657 |
| Amgen Inc. Apr 29, 2025 | Travel and Lodging Repatha · Cardiovascular · travel to CHICAGO, IL | $228 |
| Merck Sharp & Dohme LLC Apr 26, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Dallas, TX · in-kind | $440 |
| Merck Sharp & Dohme LLC Apr 26, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Dallas, TX · in-kind | $285 |
| Merck Sharp & Dohme LLC Apr 26, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Dallas, TX · in-kind | $145 |
| Merck Sharp & Dohme LLC Apr 25, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Dallas, TX · in-kind | $234 |
| Esperion Therapeutics, Inc. Mar 28, 2025 | Consulting Fee NEXLIZET; NEXLETOL · ANTILIPEMIC AGENTS | $3,300 |
| AstraZeneca Pharmaceuticals LP Mar 5, 2025 | Travel and Lodging travel to Madrid, Spain · in-kind Company’s descriptionResearch Related Service | $11,086 |
| AstraZeneca Pharmaceuticals LP Mar 5, 2025 | Travel and Lodging travel to Madrid, Spain · in-kind Company’s descriptionResearch Related Service | $675 |
| AstraZeneca Pharmaceuticals LP Mar 5, 2025 | Travel and Lodging travel to Madrid, Spain · in-kind Company’s descriptionResearch Related Service | $101 |
| AstraZeneca Pharmaceuticals LP Mar 5, 2025 | Travel and Lodging travel to Madrid, Spain · in-kind Company’s descriptionResearch Related Service | $50.51 |
| Amgen Inc. Feb 4, 2025 | Consulting Fee Repatha · Cardiovascular | $754 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.